Skip to main content
Caplight Logo









Xelcis Bio, Inc.

Xelcis Bio, Inc.

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.xelcisbio.com/

Company Overview

Xelcis Bio, Inc. is a biotechnology company that develops a biocompatible nanoparticle platform for cytosolic delivery of cancer therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

nanoparticle deliverycytosolic deliverydrug delivery platformendosomal escapebiotechnologyoncology therapeuticsdrug delivery techbiologics deliveryRNA therapeuticsprotein degradersdrug delivery startuppreclinical oncologybiocompatible nanoparticlespharma partneringdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xelcis Bio, Inc. Comparables

Compare Xelcis Bio, Inc. with similar companies based on industry and business-model similarity.

Xelcis Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iDEL Therapeutics
86%
CyGenica
78%
Entos Pharmaceuticals
76%

Xelcis Bio, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 119% MoM.

Xelcis Bio, Inc. Filings

Explore SEC and related filing metadata, where available.

Xelcis Bio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Xelcis Bio, Inc.'s valuation, stock price, and market status.

Is Xelcis Bio, Inc. a public or private company?

Xelcis Bio, Inc. is a private company.

What is the current stock price of Xelcis Bio, Inc.?

Xelcis Bio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Xelcis Bio, Inc. worth (valuation)?

Valuation information for Xelcis Bio, Inc. is not publicly available.

Can I buy Xelcis Bio, Inc. stock?

Xelcis Bio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Xelcis Bio, Inc.'s last funding round?

Funding round information for Xelcis Bio, Inc. is not publicly available.

Who are the main investors in Xelcis Bio, Inc.?

Investor information for Xelcis Bio, Inc. is not publicly disclosed.

Will Xelcis Bio, Inc. IPO soon?

No public IPO plans have been announced for Xelcis Bio, Inc..

How can I track Xelcis Bio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xelcis Bio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range4
Year Founded2024
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?